Yasamin Ostadi

Yasamin Ostadi

Auto-generated profile, based on publicly available information

Yasamin Ostadi

Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Biomaterials Research
Verified
Journal Article
Closed access
YOYasamin Ostadi
Yasamin Ostadi
JKJavad Khanali
Javad Khanali
FTFatemeh A. Tehrani
Fatemeh A. Tehrani
GYGhasem Yasdanpanah
Ghasem Yasdanpanah
SBSoheyl Bahrami
Soheyl Bahrami
HNHassan Niknejad
Hassan Niknejad
Along with a paradigm shift in looking at soft tissue fillers from space-filling to bioactive materials, decellularized extracellular matrix (DEM) fillers have gained more attention considering their superior bioactivity. However, the complex mechanisms that govern the interaction between host tissues and DEMs have been partially understood. This review first covers the mechanisms that determine immunogenicity, angiogenesis and vasculogenesis, and recellularization and remodeling after DEM implantation into host tissue, with a particular focus on related findings from filler materials. Accordingly, the review delves into the dual role of macrophages and their M1/M2 polarization paradigm to form both constructive and destructive immune responses to DEM implants. Moreover, the contribution of macrophages in angiogenesis has been elucidated, which includes but is not limited to the secretion of angiogenic growth factors and extracellular matrix (ECM) remodeling. The findings challenge the traditional view of immune cells as solely destructive entities in biomaterials and indicate their multifaceted roles in tissue regeneration. Furthermore, the review discusses how the compositional factors of DEMs, such as the presence of growth factors and matrikines, can influence angiogenesis, cell fate, and differentiation during the recellularization process. It is also shown that the biomechanical properties of DEMs, including tissue stiffness, modulate cell responses through mechanotransduction pathways, and the structural properties of DEMs, such as scaffold porosity, impact cell–cell and cell–ECM interactions. Finally, we pointed out the current clinical applications, the bottlenecks in the clinical translation of DEM biomaterials into soft tissue fillers, as well as the naïve research areas of the field.

27 November 2025 in International Journal of Drug Research in Clinics
Verified
Journal Article
Open access
PDF file
SASaba Aghajani
Saba Aghajani
AGAmir Ghaffarzad
Amir Ghaffarzad
MAMohammad Safari Asl
Mohammad Safari Asl
YOYasamin Ostadi
Yasamin Ostadi
MJMinoo Javadi
Minoo Javadi
PHParia Habibollahi
Paria Habibollahi
Background: Tramadol misuse and poisoning are serious health concerns in regions with limited prescription regulation, including Iran. Beyond its toxicologic effects, the pharmacologic properties of tramadol and associated psychosocial factors may contribute to elevated suicide risk. Accordingly, this study aimed to assess suicide risk using the SAD PERSONS scale among patients presenting with acute tramadol poisoning to the emergency department. Methods: This descriptive cross-sectional study evaluated 80 patients with confirmed tramadol poisoning presenting to Sina Hospital during 2021–2022. Demographic data, motives for tramadol use, adverse effects, and SAD PERSONS scores were collected, and suicide risk was categorized as low (0–4), moderate (5–6), or high (7–10). The obtained data were analyzed using descriptive and inferential statistical tests. Results: The mean age of participants was 36.25±6.81 years. Overall, 66.25% and 61.25% were male and single, respectively. The average daily tramadol dose was 912.96±245.16 mg. The mean SAD PERSONS score was 6.85±2.37, with 43.75%, 28.75%, and 27.5% categorized as high, moderate, and low risk, respectively. Moreover, pleasure-seeking (40%), depressive symptoms (33.75%), and sexual performance enhancement (27.5%) were the most frequently cited motives for use. Eventually, dizziness (60%), nausea (55%), and seizures (31.25%) were the most commonly reported adverse effects. Conclusion: A substantial proportion of tramadol-poisoned patients demonstrated moderate-to-high suicide risk, highlighting tramadol poisoning as a toxicologic emergency and a psychiatric crisis. Integrating structured suicide screening and timely psychiatric evaluation into emergency care is essential for early detection and prevention of recurrent self-harm.

22 June 2025 in Injury
Verified
Journal Article
Closed access
FMForouheh Moazezi
Forouheh Moazezi
RDRoya Derakhshan
Roya Derakhshan
YOYasamin Ostadi
Yasamin Ostadi
JKJavad Khanali
Javad Khanali
SZSeyed Ali Ziai
Seyed Ali Ziai
BSBabak Sabet
Babak Sabet

14 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FSFahimeh Safaeinejad
Fahimeh Safaeinejad
JKJavad Khanali
Javad Khanali
YOYasamin Ostadi
Yasamin Ostadi
MSMaryam Salimi
Maryam Salimi
NVNasim Vousooghi
Nasim Vousooghi
HNHassan Niknejad
Hassan Niknejad
Stem cells have shown potential in treating multiple sclerosis (MS) based on their capacity tonull inhibit pathogenic immune responses and release neuroprotective and oligodendrogenic molecules in favor of tissue repair. It has shown that human amniotic epithelial cells (hAECs) can release various neurotrophic, immunomodulatory, and anti-inflammatory factors; therefore, their potential as a cell therapy for MS is suggested. In this study, the synergistic therapeutic effect of hAECs and Ponesimod was investigated in the Cuprizone-induced animal model. Ponesimod is an FDA-approved drug for the treatment of MS with established immunomodulatory and neuroprotective effects. The effect of different treatment regimens was investigated, including Ponesimod, IV injection of hAECs, stereotaxic injection of hAECs, and concomitant administration of stereotaxic-injected hAECs and Ponesimod. Simultaneous administration of stereotaxic-injected hAECs and Ponesimod was the most potent in restoring Cuprizone-induced neurobehavioral deficit and brain atrophy. Immunostaining for oligodendrocytic, microglial, and astrocytic markers showed that cell and drug co-administration was superior to other treatments in rebuilding the oligodendrocyte cells in the CNS cell population and reversing Cuprizone-induced astrogliosis and microgliosis. Therefore, the combination therapy with hAECs and Ponesimod is promising in restoring the neurobehavioral deficit, pro-inflammatory glial response, and oligodendrocyte loss in the animal model, and is recommended as a candidate for treating MS.

3 August 2026 in EXCLI Journal
Verified
Journal Article
Open access
PDF file
JKJavad Khanali
Javad Khanali
YOYasamin Ostadi
Yasamin Ostadi
FTFatemeh A. Tehrani
Fatemeh A. Tehrani
TTTahereh Tayebi
Tahereh Tayebi
RTRoghayeh Tarasi
Roghayeh Tarasi
HNHassan Niknejad
Hassan Niknejad
Decellularized extracellular matrices (DEMs) have been widely investigated as promising biomaterials for soft tissue augmentation. In contrast, the use of decellularized human amniotic membrane (dHAM) represents a novel approach within this field, offering unique potential for clinical application. The objective of this study is to develop an “off-the-shelf” bioactive soft tissue filler from crosslinked and non-crosslinked dHAM in the injectable microparticle formulation. We used physical and enzymatic processes for decellularization and milling for fabricating the injectable matrix. The decellularization, crosslinking and detoxification protocol removed immunogenic cellular components, preserved collagen and glycosaminoglycan content, and reduced residual crosslinker to sub-cytotoxic levels. Consequently, both crosslinked and non-crosslinked powder extractions promoted cell viability and proliferation and did not affect cell migration in culture. Moreover, the crosslinked powder showed higher stability upon in vitro enzymatic degradation and prolonged volume retention in the subcutaneous guinea pig model. Histopathologic evaluation of the implants showed that immune cell infiltration markedly resolved over the 12-week study period. Moreover, immunohistochemistry staining for CD68 and CD163 macrophage markers indicated the abundance of CD163-positive cells, commonly associated with an anti-inflammatory or M2-like phenotype. Staining for CD31 endothelial cell marker demonstrated the formation of blood vessels with intraluminal RBCs and endothelial cell lining within the implants, which is indicative of neovascularization. Therefore, dHAM demonstrated long-term volume retention, reduced immune cell infiltration, and was associated with a CD163-positive macrophage phenotype and evidence of vascularization in the animal model. This study suggests dHAM as a readily deliverable biomaterial and a promising candidate to address clinical translational needs for soft tissue reconstruction.